Global Pompe Disease Treatment market [2016-2030] Asia Pacific by Type

Growth Outlook

• The 2030] Asia Pacific by Type portion of the Global Pompe Disease Treatment market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 315 Mn in 2026 and is projected to reach USD 363 Mn by 2030 — a gain of about 15% over the forecast period, translating to a CAGR in the mid-single digits.
• late onset pompe disease segment accounted for the largest market share in 2018, this market is expected to reach USD 218. 40 Million in 2030 from USD 149.
• What the regional split looks like (2026): Late Onset Pompe Disease leads, holding roughly 60% of segment value — the single largest regional share. Classic Infantile Onset Pompe Disease is the second-largest contributor. Non Classic Infantile Onset Pompe Disease make up the remainder, in descending order.
• By 2030, Late Onset Pompe Disease alone is expected to reach USD 218 Mn, with Classic Infantile Onset Pompe Disease at USD 105 Mn.

Market Dynamics

late onset pompe disease segment accounted for the largest market share in 2018, this market is expected to reach USD 218.40 Million in 2030 from USD 149.40 Million in 2018. This market is projected to grow at a CAGR of 3.27% during the forecast period from 2019 - 2030. However, late onset pompe disease segment is the fastest growing market, which is expected to grow at a CAGR of 3.27% during the forecast period 2019 - 2030.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.